We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Shihab Hameed

Shihab Hameed BSc (Med), MBBS (Hons), PhD, DCH, FRACP

Pediatric Endocrinologist Sydney Children’s Hospital, Randwick and Royal North Shore Hospital St Leonards; Conjoint Senior Lecturer University of New South Wales, Kensington; Clinical Senior Lecturer, University of Sydney, New South Wales, Australia

Dr. Shihab Hameed is a Senior Staff Specialist Pediatric Endocrinologist at Sydney Children’s Hospital, and Royal North Shore Hospitals in Sydney, Australia as well as a Senior Conjoint Lecturer at the University of New South Wales and a Senior Clinical Lecturer at the University of Sydney. Dr. Hameed has a special research interest in the diagnosis and management of cystic fibrosis related diabetes (CFRD). He completed his Doctor of Philosophy in 2017 on “Monogenic and Cystic Fibrosis Related Diabetes in Childhood”, and is a co-author of the International Society for Pediatric and Adolescent Diabetes Guidelines on the Management of cystic fibrosis-related diabetes in children and adolescents. He is a chief investigator in the CF-IDEA trial (Cystic Fibrosis – Insulin Deficiency, Early Action, clinicaltrials.gov NCT01100892) a randomized controlled trial of once-daily insulin treatment in children and adolescents with early insulin deficiency. He also has a strong interest in diabetes technologies, including continuous glucose monitoring.

Recent Contributions to PracticeUpdate:

  1. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis